General Gynecology and Pelvic Floor
Zahra Yazdi; Hoora Amuzegar; Monireh Mirzaie; Seyed Mohammad Hashem Montazeri
Volume 8, Issue 2 , March and April 2023, , Pages 188-193
Abstract
We present a 26-year-old woman with hypothyroidism that was treated with levothyroxine, and was hospitalized at 25 weeks of gestational age with diagnosis of ovarian torsion and underwent detorsion surgery, but finally, after a few weeks and during cesarean section, no trace and evidence of the ovary ...
Read More
We present a 26-year-old woman with hypothyroidism that was treated with levothyroxine, and was hospitalized at 25 weeks of gestational age with diagnosis of ovarian torsion and underwent detorsion surgery, but finally, after a few weeks and during cesarean section, no trace and evidence of the ovary was observed, which suggests the phenomenon of spontaneous ovarian absorption.
Obstetrics and Gynecology
Farzaneh Boroumand; Shiva Ghayur; Rasoul Gharaaghaji; Shabnam Vazifekhah
Volume 7, Issue 6 , September and October 2022, , Pages 524-529
Abstract
Background & Objective: Maternal obesity can increases pregnancy consequences like postpartum hemorrhage, preeclampsia, need for cesarean section, neonatal death, and fetal macrosomia. In this study, the efficacy of prophylactic use of metformin to prevent gestational diabetes mellitus in nondiabetic ...
Read More
Background & Objective: Maternal obesity can increases pregnancy consequences like postpartum hemorrhage, preeclampsia, need for cesarean section, neonatal death, and fetal macrosomia. In this study, the efficacy of prophylactic use of metformin to prevent gestational diabetes mellitus in nondiabetic pregnant women with obesity was examined.Materials & Methods: This study was a clinical trial. Totally, 340 pregnant women who were in the first trimester were referred to the gynecology clinic of Motahhari hospital in Urmia after ensuring the absence of underlying diseases such as diabetes, hypertension, kidney, liver, and cardiovascular disease, without a history of allergy to metformin, in case of a singleton pregnancy, and Body Mass Index (BMI) above 30 were allocated to two equal groups. The intervention group was given 1000 mg of metformin, and the control group was given a placebo. Demographic information, including age, gravity, parity, live birth, birth, and maternal weight, previous delivery method, abortion, delivery method with its cause, polyhydramnios, NICU hospitalization, gestational age, mortality, and neonatal anomalies was also recorded. The results were analyzed using SPSS version 26.Results: In the control group, 15 mothers (9.4%) out of 160 people, and in the intervention group, 13 mothers (8.1%) had gestational diabetes (P < /i>=0.692). In the intervention group, the mean insulin dose was 10.8 ±3 units; in the control group, the mean insulin dose was 21.2±15.7 units (P=0.048). Twenty patients (6.7%) out of 297 obese patients and 8 patients (34.8%) in the morbid obesity group had diabetes (P < /i><0.001). In the control group, the mean weight of mothers was 8.04±2.5 kg; in the intervention group, it was 5.2±2.3 kg during pregnancy (P < /i><0.001). Gestational diabetes, delivery method, death one week after birth, preterm birth, polyhydramnios, and intensive care unit were similar in the two groups. Conclusion: Metformin in pregnant women with a BMI>30 deals with low maternal weight, reduced birth weight, and reduced insulin dose in diabetic mothers.
